BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31161834)

  • 1. Have nanomedicines progressed as much as we'd hoped for in drug discovery and development?
    Sarmento B
    Expert Opin Drug Discov; 2019 Aug; 14(8):723-725. PubMed ID: 31161834
    [No Abstract]   [Full Text] [Related]  

  • 2. Issues affecting nanomedicines on the way from the bench to the market.
    Longo JPF; Mussi S; Azevedo RB; Muehlmann LA
    J Mater Chem B; 2020 Dec; 8(47):10681-10685. PubMed ID: 33155000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Molecular Vaccines Against Pathogens in the Post-genomic Era.
    OƱate AA; Wan Y; Moreno A
    Front Cell Infect Microbiol; 2019; 9():443. PubMed ID: 32039041
    [No Abstract]   [Full Text] [Related]  

  • 4. Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data.
    Conrado DJ; Duvvuri S; Geerts H; Burton J; Biesdorf C; Ahamadi M; Macha S; Hather G; Francisco Morales J; Podichetty J; Nicholas T; Stephenson D; Trame M; Romero K; Corrigan B;
    Clin Pharmacol Ther; 2020 Apr; 107(4):796-805. PubMed ID: 31955409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine: is it lost in translation?
    Greish K; Mathur A; Bakhiet M; Taurin S
    Ther Deliv; 2018 Mar; 9(4):269-285. PubMed ID: 29495928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulating target engagement of small molecules via drug delivery: approaches and applications in drug discovery and development.
    Yang W; Bhattachar SN; Patel PJ; Landis M; Patel D; Reid DL; Duvnjak Romic M
    Drug Discov Today; 2021 Mar; 26(3):713-723. PubMed ID: 33333320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial drug discovery: lessons of history and future strategies.
    Travis A; Chernova O; Chernov V; Aminov R
    Expert Opin Drug Discov; 2018 Nov; 13(11):983-985. PubMed ID: 30136874
    [No Abstract]   [Full Text] [Related]  

  • 8. Physiologically-based modeling of monoclonal antibody pharmacokinetics in drug discovery and development.
    Glassman PM; Balthasar JP
    Drug Metab Pharmacokinet; 2019 Feb; 34(1):3-13. PubMed ID: 30522890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AI for drug discovery is advancing rapidly: We need smart biology for it to fulfill its mission.
    Ushio M; Carpenter Z
    Drug Discov Today; 2022 Jan; 27(1):1-2. PubMed ID: 34634477
    [No Abstract]   [Full Text] [Related]  

  • 10. Building the future of drug discovery.
    Bloom B
    Drug Discov Today; 2021 Apr; 26(4):863-864. PubMed ID: 33548463
    [No Abstract]   [Full Text] [Related]  

  • 11. A Perspective on Synthetic Biology in Drug Discovery and Development-Current Impact and Future Opportunities.
    David F; Davis AM; Gossing M; Hayes MA; Romero E; Scott LH; Wigglesworth MJ
    SLAS Discov; 2021 Jun; 26(5):581-603. PubMed ID: 33834873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological research and pluripotent stem cells: from the innovative experimental paradigm to the successful clinical trial].
    Baghdoyan S; Bassez G; Audureau E; Peschanski M
    Med Sci (Paris); 2019 Jan; 35(1):26-29. PubMed ID: 30672450
    [No Abstract]   [Full Text] [Related]  

  • 13. Where Are the Nanodrugs? An Industry Perspective on Development of Drug Products Containing Nanomaterials.
    Havel HA
    AAPS J; 2016 Nov; 18(6):1351-1353. PubMed ID: 27520380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in development of nanoparticle-based therapeutics.
    Desai N
    AAPS J; 2012 Jun; 14(2):282-95. PubMed ID: 22407288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering Microbial Living Therapeutics: The Synthetic Biology Toolbox.
    Pedrolli DB; Ribeiro NV; Squizato PN; de Jesus VN; Cozetto DA;
    Trends Biotechnol; 2019 Jan; 37(1):100-115. PubMed ID: 30318171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRAC channels as targets for drug discovery and development.
    Stauderman KA
    Cell Calcium; 2018 Sep; 74():147-159. PubMed ID: 30075400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leveraging Humanized Animal Models to Understand Human Drug Disposition: Opportunities, Challenges, and Future Directions.
    Choo EF; Salphati L
    Clin Pharmacol Ther; 2018 Feb; 103(2):188-192. PubMed ID: 29193027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Genetic Variants in the Targets of Lipid Lowering Therapies to Inform Drug Discovery and Development: Current and Future Treatment Options.
    Ference BA
    Clin Pharmacol Ther; 2019 Mar; 105(3):568-581. PubMed ID: 29953581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of nanotechnology on medicinal chemistry and drug discovery.
    Yan B
    Curr Med Chem; 2011; 18(14):2044. PubMed ID: 21517771
    [No Abstract]   [Full Text] [Related]  

  • 20. Are we seeing a resurgence in the use of natural products for new drug discovery?
    Li F; Wang Y; Li D; Chen Y; Dou QP
    Expert Opin Drug Discov; 2019 May; 14(5):417-420. PubMed ID: 30810395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.